A Relative Bioavailability Study of Propranolol Hydrochloride 160 mg Tablets Under Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-03-19
- Last Posted Date
- 2010-08-17
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT00865215
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
A Relative Bioavailability Study of Propranolol HCl 160 mg Tablets Under Non-fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-03-19
- Last Posted Date
- 2010-08-17
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT00864747
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
A Relative Bioavailability Study of Bupropion XL 150 mg Tablets Under Fed Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: Abrika Bupropion 150 mg XL Tablet, single dose
- First Posted Date
- 2009-03-19
- Last Posted Date
- 2010-08-16
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT00865462
- Locations
- 🇺🇸
SFBC Ft. Myers, Inc., Ft. Myers, Florida, United States
A Relative Bioavailability Study of Bupropion Extended-Released 150 mg Tablets Under Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-03-19
- Last Posted Date
- 2010-08-16
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT00865410
- Locations
- 🇺🇸
SFBC Ft. Myers, Inc., Ft. Myers, Florida, United States
A Relative Bioavailability Study of Bupropion Extended-Released 150 mg Tablets Under Fed Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-03-19
- Last Posted Date
- 2010-08-16
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT00865371
- Locations
- 🇺🇸
SFBC Ft. Myers, Inc., Ft. Myers, Florida, United States
A Relative Bioavailability Study of Bupropion Sustained Release 150 mg Tablets Under Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-03-19
- Last Posted Date
- 2010-08-16
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT00865111
- Locations
- 🇺🇸
SFBC Ft. Myers, Inc., Ft. Myers, Florida, United States
A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Non-fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: CLUCOVANCE® 5 mg/500 mg Tablets, single dose
- First Posted Date
- 2009-03-19
- Last Posted Date
- 2010-08-17
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT00864734
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
A Relative Bioavailability Study of Alprazolam 3 mg Extended Release Tablets Under Non-fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-03-19
- Last Posted Date
- 2010-08-17
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT00865657
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
Single Dose Two-Way Crossover Fed Bioequivalence Study of Nabumetone 750 mg Tablets in Healthy Volunteers
- First Posted Date
- 2009-03-19
- Last Posted Date
- 2020-01-07
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT00864604
- Locations
- 🇺🇸
AAIPharma Inc., AAI Clinic, Morrisville, North Carolina, United States
A Relative Bioavailability Study of Oxycodone 5 mg / Ibuprofen 400 mg Tablets Under Non-fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: COMBONOX® tablets, single dose
- First Posted Date
- 2009-03-18
- Last Posted Date
- 2010-08-17
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT00864357
- Locations
- 🇺🇸
Gateway Medical Research, Inc, St. Charles, Missouri, United States
© Copyright 2025. All Rights Reserved by MedPath